Mangoceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Mangoceuticals's balance sheet done over the years? Its assets were worth $1,050,793 last year, which is more than in the previous period. 26% of Mangoceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $276,039, which means an decrease by -29% compared compared to last year.

Debt to Assets

Mangoceuticals, Inc. (NASDAQ:MGRX): Debt to assets
2021 22550 39.27K 174.15%
2022 1003287 389.25K 38.8%
2023 1050793 276.03K 26.27%

MGRX Balance Sheet (2021 – 2023)

2023 2022 2021
Assets
Current assets:
Cash and cash equivalents
739.00K682.86K22.55K
Short term investments
000
Net receivables
000
Inventory
18.50K00
Other current assets
60.95K11.74K0
Total current assets
818.46K694.60K22.55K
Non-current assets:
Property, Plant and Equipment
215.39K291.74K0
Goodwill
000
Intangible assets
000
Long term investments
000
Other non-current assets
16.94K16.94K0
Total non-current assets
232.33K308.68K0
Total assets
1.05M1.00M22.55K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
000
Short term debt
127.43K224.18K39.27K
Total current liabilities
211.07K260.57K39.27K
Non-current liabilities:
Long term debt
64.96K128.68K0
Deferred tax
000
Other non-current liabilities
000
Total non-current liabilities
64.96K128.68K0
Total liabilities
276.03K389.25K39.27K
Data source